AllianceBernstein
MRNS

AllianceBernstein’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

AllianceBernstein’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,300
Closed -$373K – 3342
2024
Q1 		$373K Buy
41,300
+2,030
+5% +$19.7K ﹤0.01% 2720
2023
Q4 		$427K Buy
39,270
+4,580
+13% +$34.3K ﹤0.01% 2687
2023
Q3 		$279K Buy
34,690
+8,700
+33% +$72.4K ﹤0.01% 2832
2023
Q2 		$282K Buy
+25,990
New +$223K ﹤0.01% 2890
2022
Q2 		– Sell
-20,024
Closed -$187K – 3417
2022
Q1 		$187K Hold
20,024
– – ﹤0.01% 3009
2021
Q4 		$238K Hold
20,024
– – ﹤0.01% 3015
2021
Q3 		$228K Hold
20,024
– – ﹤0.01% 3054
2021
Q2 		$359K Buy
20,024
+2,000
+11% +$32.2K ﹤0.01% 2960
2021
Q1 		$279K Sell
18,024
-3,900
-18% -$56.4K ﹤0.01% 2935
2020
Q4 		$267K Buy
+21,924
New +$306K ﹤0.01% 2908
2020
Q3 		– Sell
-26,075
Closed -$265K – 3221
2020
Q2 		$265K Buy
26,075
+12,850
+97% +$118K ﹤0.01% 2932
2020
Q1 		$107K Buy
13,225
+6,950
+111% +$60.2K ﹤0.01% 2947
2019
Q4 		$54K Hold
6,275
– – ﹤0.01% 3092
2019
Q3 		$39K Hold
6,275
– – ﹤0.01% 3137
2019
Q2 		$104K Buy
6,275
+2,250
+56% +$39.1K ﹤0.01% 3077
2019
Q1 		$67K Sell
4,025
-3,025
-43% -$43.6K ﹤0.01% 3063
2018
Q4 		$81K Hold
7,050
– – ﹤0.01% 3014
2018
Q3 		$282K Buy
7,050
+1,850
+36% +$52.6K ﹤0.01% 2876
2018
Q2 		$147K Buy
+5,200
New +$115K ﹤0.01% 3018

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's MRNS Position: Q2 2024 in Review

AllianceBernstein sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 41,300 shares — an estimated $373K sold.

AllianceBernstein first reported a position in MRNS in Q2 2018 and held it in 19 quarters. The position peaked at $427K in Q4 2023. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • AllianceBernstein reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • AllianceBernstein sold 41,300 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $373K.
  • AllianceBernstein first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 19 quarters.
  • AllianceBernstein's Marinus Pharmaceuticals, Inc position peaked at $427K in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.